✦ LIBER ✦

Implications of Vancomycin Degradation Products on Therapeutic Drug Monitoring in Patients with End-Stage Renal Disease

✍ Scribed by Allison L. Somerville; Dr. David H. Wright; Dr. John C. Rotschafer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased advanced glycation end product

✍ Noriyuki Sakata; Yoshinobu Imanaga; Jing Meng; Yutaka Tachikawa; Shigeo Takebaya 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 1011 KB

The Role of Ambulatory Blood Pressure Mo

✍ Jhoong S. Cheigh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB

Preferable timing of therapeutic drug mo

✍ Takahashi, Yoshiko; Takubo, Shingo; Ishihara, Mika; Takesue, Yoshio; Nakajima, K 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 443 KB

Erratum to: Preferable timing of therape

✍ Takahashi, Yoshiko; Takubo, Shingo; Ishihara, Mika; Takesue, Yoshio; Nakajima, K 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 396 KB

Increased production of proinflammatory

✍ Tomas Roubicek; Marketa Bartlova; Jana Krajickova; Denisa Haluzikova; Milos Mraz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 445 KB

The pharmacokinetics of etanercept in pa

✍ Burl R. Don; Gregory Spin; Aubri Rose; Ivan Nestorov; Matt Hutmacher; George A. 📂 Article 📅 2005 🏛 Pharmaceutical Press 🌐 English ⚖ 265 KB